GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,415.50p
   
  • Change Today:
      19.00p
  • 52 Week High: 1,788.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,102.45m
  • Volume: 7,105,611
  • Market Cap: £58,070m
  • RiskGrade: 129
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
3.39% below the market average3.39% below the market average3.39% below the market average3.39% below the market average3.39% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
1yr Revenue Growth
2.95% below the market average2.95% below the market average2.95% below the market average2.95% below the market average2.95% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
22.83% above the market average22.83% above the market average22.83% above the market average22.83% above the market average22.83% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
1yr DPS Growth
6.34% above the market average6.34% above the market average6.34% above the market average6.34% above the market average6.34% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
9.89% below the market average9.89% below the market average9.89% below the market average9.89% below the market average9.89% below the market average
62.96% below the sector average62.96% below the sector average62.96% below the sector average62.96% below the sector average62.96% below the sector average
Price Book Ratio
76.05% below the market average76.05% below the market average76.05% below the market average76.05% below the market average76.05% below the market average
38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
6.69% above the market average6.69% above the market average6.69% above the market average6.69% above the market average6.69% above the market average
6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average
Price Chg 3m
16.44% below the market average16.44% below the market average16.44% below the market average16.44% below the market average16.44% below the market average
19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
11.92% below the market average11.92% below the market average11.92% below the market average11.92% below the market average11.92% below the market average
2.33% above the sector average2.33% above the sector average2.33% above the sector average2.33% above the sector average2.33% above the sector average
Momentum 20
79.36% above the market average79.36% above the market average79.36% above the market average79.36% above the market average79.36% above the market average
76.74% above the sector average76.74% above the sector average76.74% above the sector average76.74% above the sector average76.74% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
18.17% above the market average18.17% above the market average18.17% above the market average18.17% above the market average18.17% above the market average
70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average
ROCE
69.56% above the market average69.56% above the market average69.56% above the market average69.56% above the market average69.56% above the market average
Sector averageSector averageSector averageSector averageSector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.58% above the market average91.58% above the market average91.58% above the market average91.58% above the market average91.58% above the market average
91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average
Forecast EPS
79.01% above the market average79.01% above the market average79.01% above the market average79.01% above the market average79.01% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.84% above the market average97.84% above the market average97.84% above the market average97.84% above the market average97.84% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average
Operating Profit Loss
97.94% above the market average97.94% above the market average97.94% above the market average97.94% above the market average97.94% above the market average
95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.23% above the market average97.23% above the market average97.23% above the market average97.23% above the market average97.23% above the market average
95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average
Cash
96.84% above the market average96.84% above the market average96.84% above the market average96.84% above the market average96.84% above the market average
95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
74.35% above the market average74.35% above the market average74.35% above the market average74.35% above the market average74.35% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Buys 1y
99.11% above the market average99.11% above the market average99.11% above the market average99.11% above the market average99.11% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
92.38% below the market average92.38% below the market average92.38% below the market average92.38% below the market average92.38% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Brokers Percent Neutral
78.18% above the market average78.18% above the market average78.18% above the market average78.18% above the market average78.18% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,415.50p
Change Today 19.00p
% Change 1.36 %
52 Week High 1,788.50
52 Week Low 1,264.00
Volume 7,105,611
Shares Issued 4,102.45m
Market Cap £58,070m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
37.39% below the market average37.39% below the market average37.39% below the market average37.39% below the market average37.39% below the market average
19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average
Price Trend
1.07% below the market average1.07% below the market average1.07% below the market average1.07% below the market average1.07% below the market average
36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average36.17% above the sector average
Income
75.72% above the market average75.72% above the market average75.72% above the market average75.72% above the market average75.72% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
39.22% below the market average39.22% below the market average39.22% below the market average39.22% below the market average39.22% below the market average
48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average48.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 20-May-2025

Time Volume / Share Price
16:08 5 @ 1,410.00p
16:08 5 @ 1,410.00p
16:08 5 @ 1,410.00p
15:43 0 @ 1,414.50p
15:45 0 @ 1,414.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page